Chronic Lymphocytic Leukemia News and Research

RSS
Chronic Lymphocytic Leukemia (CLL) is the most common form of leukemia in adults. According to the American Cancer Society, approximately 8,000 patients will be diagnosed this year. More than 60,000 people in the U.S. currently have CLL. The disease arises in lymphocytes, a type of white blood cell that normally produces antibodies and serves important immune functions.
Homogenous BTK occupancy assay used in tirabrutinib clinical studies

Homogenous BTK occupancy assay used in tirabrutinib clinical studies

New findings refine link between clonal hematopoiesis and blood cancer risk

New findings refine link between clonal hematopoiesis and blood cancer risk

Researchers complete genomic map of chronic lymphocytic leukemia

Researchers complete genomic map of chronic lymphocytic leukemia

Celgene to share new and updated data around novel hematological therapies

Celgene to share new and updated data around novel hematological therapies

Researchers test new cancer research model that may reduce cost and speed up studies

Researchers test new cancer research model that may reduce cost and speed up studies

New T cell biomarker could be much-needed patient-selection tool for CAR T cell therapy

New T cell biomarker could be much-needed patient-selection tool for CAR T cell therapy

Research reveals immune suppressive role of soluble antibodies in tumor progression

Research reveals immune suppressive role of soluble antibodies in tumor progression

Scripps Florida researchers awarded $2.875 million to destroy common form of leukemia

Scripps Florida researchers awarded $2.875 million to destroy common form of leukemia

Study reveals a loophole in treatment of chronic lymphocytic leukemia

Study reveals a loophole in treatment of chronic lymphocytic leukemia

FDA researchers find underrepresentation of adults aged 75 years and older in blood cancer clinical trials

FDA researchers find underrepresentation of adults aged 75 years and older in blood cancer clinical trials

Study: Combination targeted therapy has high response rates in AML patients

Study: Combination targeted therapy has high response rates in AML patients

Combination of chemotherapy and targeted drug improves response in younger CLL patients

Combination of chemotherapy and targeted drug improves response in younger CLL patients

CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients

CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients

Study: Cancer patients willing to swap drug efficacy for reduced risk of adverse events

Study: Cancer patients willing to swap drug efficacy for reduced risk of adverse events

Penn researchers provide new insights into how Notch drives growth of B-cell cancers

Penn researchers provide new insights into how Notch drives growth of B-cell cancers

Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

Tattoo ink from 15 years ago mimics lymph node cancer: Case study

Tattoo ink from 15 years ago mimics lymph node cancer: Case study

UC San Diego researchers receive $18.2 million grant for B cell cancer clinical trial

UC San Diego researchers receive $18.2 million grant for B cell cancer clinical trial

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

Shaping the future of oncology treatment

Shaping the future of oncology treatment